Delivery Order SPE2DB20D1100-SPE2DB25FD4N6
Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $24,085.78 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye (pancrelipase) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed price, competitively awarded delivery order represents a small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The order will be fulfilled from the company's Conshohocken, Pennsylvania location, where the company...
- The Defense Logistics Agency awarded a $4,464.24 firm fixed price delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye on June 9, 2025, with an ultimate completion date of June 10, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $21,717.63 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye DR 200S on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside, firm fixed price delivery order is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $2,136.78 delivery order to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye (pancrelipase) on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, while its parent organization is Cencora, Inc. (doing business as AmerisourceBergen)....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,946.55 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s. This is a firm fixed price, non-set-aside contract awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Pertzye (pancrelipase) capsules—16,000 units in 100-count bottles. This competitive, non-set-aside contract has a ceiling value of $5,750.73 and a firm fixed price structure, with an ultimate completion date of October 29, 2025. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a $18,068.84 delivery order to AmerisourceBergen Drug Corp for 16,000 unit capsules of PERTZYE DR 100S, with a completion deadline of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 16,000 units of the drug Pertzye (a medication used to treat exocrine pancreatic insufficiency) in 100-count capsule bottles. The contract is a firm-fixed-price delivery order valued at $15,708.21, with a completion date of December 29, 2023. AmerisourceBergen is the prime contractor, and the contract was awarded on December 28,...
- This federal contract award is for the delivery of 16,000 units of the pharmaceutical product Pertzye DR 16,000 Unit Capsule to the Defense Logistics Agency (DLA). The $4,954.01 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 11, 2023, with a completion date of May 12, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a $5,094.25 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, identified as SPE2DB22D3004|SPE2DB24FRM37, is for the supply of 24,000 units of the pharmaceutical product Pertzye DR 80 mg capsule. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds multiple Indefinite...